Skip to main content

Articles

Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets

Stakeholder Perspective

Health Economics and Outcomes Research Data Key in Coverage Decisions of New Medications

Industry Trends

The Policy-Driven Health Plan: A Road Map for Value-Based Reimbursement

Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care

Stakeholder Perspective

Reconsidering the Management of Younger Patients with Myelodysplastic Syndrome

Getting Back to Reality: The Election, the Fiscal Cliff, and the ACA

APPENDIX: Detailed Methods

Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes

Multiple Sclerosis

Multiple Sclerosis: Patient Characteristics and Cost Concerns

Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study

Stakeholder Perspective

Parkinson’s Disease: A Complicated but Underappreciated and Undertreated Condition

Industry Trends

Cost Management through Care Management, Part 2: The Importance of Managing Specialty Drug Utilization in the Medical Benefit

Medical Care Costs and Hospitalization in Patients with Bipolar Disorder Treated with Atypical Antipsychotics

Stakeholder Perspective

The Potential Value of Benefit Design and Medication Selection for a Total-Cost-of-Care Strategy in Bipolar Disease

Page 192 of 246
Results 1911 - 1920 of 2458